Couverture de GAAP Advisors | Ind AS Clinic Podcasts

GAAP Advisors | Ind AS Clinic Podcasts

GAAP Advisors | Ind AS Clinic Podcasts

De : GAAP Advisors
Écouter gratuitement

Mastering the Language of Financial Reporting Stay ahead of the curve in the evolving world of global accounting. The Ind AS Clinic provides expert technical analysis and practical insights into Indian Accounting Standards (Ind AS), IFRS, and Indian GAAP. Hosted by CA Manish C. Iyer, this podcast breaks down complex regulatory updates into actionable knowledge. Whether you are a chartered accountant, a finance professional, or a student, tune in for deep dives into Standard ClarificationsGAAP Advisors
Épisodes
  • Classification of Investment in Non-cumulative Bonds - Ind AS 32 and Ind AS 109
    Jul 4 2026
    Ever wondered if the simple label on your investment could fundamentally change your financial reporting? This source dives into a critical accounting dilemma under Ind AS 109: how to classify investments in non-cumulative vs. cumulative bonds.While Company A expects regular interest from its non-cumulative bonds based on past trends, the source reveals that "expectations" aren't enough to satisfy the rigorous Contractual Cash Flow Test (CCFT). For a bond to be measured at Fair Value through Other Comprehensive Income (FVOCI), it must meet the SPPI (Solely Payments of Principal and Interest) criteria.The real intrigue lies in a technicality that many investors overlook: the time value of money. The source explains that even a bond labeled "cumulative" might fail the SPPI test if it only pays simple interest. For a bond to truly mirror a "basic lending arrangement," it must provide interest on unpaid interest. If this condition isn't met, the nomenclature doesn't matter—the bond fails the test and cannot be classified as FVOCI.Explore these excerpts to understand why the fine print of a bond's interest structure is more important for its accounting classification than its "cumulative" title.
    Afficher plus Afficher moins
    38 min
  • Hiding market volatility with mutual funds - Ind AS 1, Ind AS 32 and Ind AS 109
    Jul 3 2026
    This marks the launch of 50th Podcast.This source exposes a common but significant accounting error: misclassifying mutual fund investments to hide market volatility.The review focuses on a company that measured units of the "Small is Beautiful" fund at Fair Value through Other Comprehensive Income (FVTOCI). While this might seem like a standard choice, the source reveals a technical trap under Ind AS 109. This specific measurement option is strictly reserved for equity instruments.The twist lies in the nature of the investment. A mutual fund unit is a puttable instrument, which Ind AS 32 identifies as a financial liability rather than an equity instrument for the holder. Consequently, these units must be measured at Fair Value through Profit or Loss (FVTPL). By bypassing the profit and loss account, the company not only misapplied Ind AS 109 but also violated Ind AS 1 by failing to provide transparent disclosures, effectively obscuring information from shareholders.This source serves as a cautionary tale for investors and auditors alike. It raises a provocative question: Are companies intentionally misclassifying assets to "protect" their profit figures from market fluctuations? Understanding this subtle distinction between equity and puttable instruments is key to uncovering the true financial health of an entity.
    Afficher plus Afficher moins
    45 min
  • Impairment of Investment in Associate - Ind AS 28, Ind AS 36 and Ind AS 109
    Jul 2 2026
    This source investigates a high-stakes accounting dilemma: what happens when an investment in an associate loses significant value before the ink on the transfer is even dry? While many practitioners might instinctively look to Ind AS 109 (Financial Instruments) to handle the fallout, the source reveals a critical regulatory trap—Ind AS 109 specifically excludes these types of equity interests.Through a detailed technical response, the source navigates the intersection of Ind AS 28 and Ind AS 36, identifying that a "significant or prolonged decline" in market price below cost constitutes objective evidence of impairment. It challenges the reader to look beyond basic financial instrument rules to find the correct path for reporting such losses.By addressing whether a sharp quoted price drop is a sufficient indicator for a formal impairment test, this source uncovers the subtle but vital boundaries between different accounting frameworks. It raises a compelling question for investors and auditors alike: Are companies correctly identifying when a market dip necessitates a full-scale impairment review, or are they misapplying standards and masking the true decline in their asset values?
    Afficher plus Afficher moins
    39 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment